CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival Meeting Abstract

  

Authors:	Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; Sauter, C. S.; van den Brink, M. R. M.; Young, J. W.; Giralt, S. A.; Perales, M. A.; Ponce, D. M.
Abstract Title:	CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
Meeting Title:	2016 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	22
Issue:	3 Suppl. 1
Meeting Dates:	2016 Feb 18-22
Meeting Location:	Honolulu, HI
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2016-03-01
Start Page:	S389
Language:	English
ACCESSION:	WOS:000370910300585
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2015.11.909
Notes:	Meeting Abstract: 584 -- BMT Tandem Meetings -- FEB 18-22, 2016 -- Honolulu, HI -- 1 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/91714